Social Media Ideas for New Drugs

The Drug Changing Medicine

By EMANUEL SARKEES The United States is in the middle of what researchers are calling one of the most significant pharmacological developments in modern medicine. GLP-1 receptor ag...

PEPTIDE-L WAVE! PCAC Approves Four Bulk Drug Substances for the 503A List

By Karla L. Palmer & Charles D. Snow & Mary Bass —

The PEPTIDE-L Wave Rolls On! PCAC Adds Two More Bulk Drug Substances for the 503A List

By Charles D. Snow & Karla L. Palmer & Mary Bass —

A new kind of drug will help fight previously untreatable conditions

The first of a new generation of drugs that works in a completely different way to existing ones has been approved. Columnist Michael Le Page says this approach could transform tre...

<![CDATA[FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV,...

Takeda approval ushers in new wave of sleep drugs

An FDA nod mostly clears the way for Orzeyful to enter, by Wall Street estimates, a multibillion-dollar market for drugs that boost “orexin” proteins.

FDA Panel Backs Two Peptides For Compounding, Rejects One

MONDAY, July 27, 2026 — A federal advisory panel has recommended allowing compounding pharmacies to make two more unproven peptides while voting to reject a third.The U.S. Food an...

FDA Panel Approves Several ‘Biohacking’ Drugs Amid Growing Social Media Demand

by Spencer Lombardo at CDN - An advisory panel narrowly approved multiple drugs that some are hailing as a victory for the Make America Healthy Again movement and others are sayin...

New Jazz cancer drug approval could drive blockbuster sales

Ziihera can now be used as an initial treatment for all HER2-positive gastroesophageal adenocarcinomas, dramatically expanding the drug’s market potential.

New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many

Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more.

New Melanoma Drug, Tudriqev, Based On Herpes Virus Granted FDA Accelerated Approval

MONDAY, Aug. 10, 2026 — Federal regulators have granted accelerated approval to a novel therapy for advanced melanoma — giving doctors another weapon to fight this challenging skin...

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Simtriyo]]>

FDA committee recommends looser restrictions for several peptides

An FDA committee is recommending the addition of several peptides to the 503A bulk drug substances list.The FDA’s Pharmacy Compounding Advisory Committee, which has faced scrutiny...

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Orezeyful]]>

New cancer drugs approved for use by NHS in Scotland

New cancer treatments have been approved for use by the NHS in Scotland

Compounded Ozempic, Zepbound Still Widely Available Despite End Of Drug Shortages

TUESDAY, July 21, 2026 — Americans are still buying compounded versions of Ozempic and Zepbound more than a year after federal regulators declared that shortages of those weight-l...

Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA

Rasonque’s speedy approval — just a month after a completed submission — represents a paradigm shift for a notoriously deadly cancer and begins what analysts see as a highly lucrat...

<![CDATA[FDA's New Frontier: Drug Pricing Enters the Conversation]]>

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Pasatru]]>

FDA Approves New Pill, Etcamah, For Advanced Breast Cancer Guided By Blood Test

TUESDAY, Sept. 8, 2026 — The U.S. Food and Drug Administration (FDA) has approved a new daily pill for adults with advanced breast cancer whose tumors have found a way around their...

<![CDATA[FDA Pannel Votes to Loosen Restrictions for Four Peptides ]]>

<![CDATA[FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma]]>

Regeneron to challenge Ipsen as FDA clears bone disease drug

Pasatru’s approval sets up a market battle in a rare indication where the only available treatment has generated disappointing sales.

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Zanvastro]]>